Erratum: P-147 Clinical efficacy of certolizumab pegol in patients with Crohn's disease based on moderate versus severe activity in the PRECiSE-2 trial (Inflammatory Bowel Diseases (2013) 19 (S83))

Stephen Hanauer, Marla Dubinsky, Jason Coarse, David Rubin

Research output: Contribution to journalComment/debatepeer-review

1 Scopus citations
Original languageEnglish (US)
Pages (from-to)E9
JournalInflammatory bowel diseases
Volume20
Issue number2
DOIs
StatePublished - Feb 2014

ASJC Scopus subject areas

  • Immunology and Allergy
  • Gastroenterology

Cite this